Cargando…
Two issues should be noted when designing a clinical trial to evaluate BCG effects on COVID-19
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242049/ https://www.ncbi.nlm.nih.gov/pubmed/37287961 http://dx.doi.org/10.3389/fimmu.2023.1207212 |
_version_ | 1785054126301773824 |
---|---|
author | Gong, Wenping Liu, Yinping Xue, Yong Zhuang, Li |
author_facet | Gong, Wenping Liu, Yinping Xue, Yong Zhuang, Li |
author_sort | Gong, Wenping |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10242049 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102420492023-06-07 Two issues should be noted when designing a clinical trial to evaluate BCG effects on COVID-19 Gong, Wenping Liu, Yinping Xue, Yong Zhuang, Li Front Immunol Immunology Frontiers Media S.A. 2023-05-23 /pmc/articles/PMC10242049/ /pubmed/37287961 http://dx.doi.org/10.3389/fimmu.2023.1207212 Text en Copyright © 2023 Gong, Liu, Xue and Zhuang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Gong, Wenping Liu, Yinping Xue, Yong Zhuang, Li Two issues should be noted when designing a clinical trial to evaluate BCG effects on COVID-19 |
title | Two issues should be noted when designing a clinical trial to evaluate BCG effects on COVID-19 |
title_full | Two issues should be noted when designing a clinical trial to evaluate BCG effects on COVID-19 |
title_fullStr | Two issues should be noted when designing a clinical trial to evaluate BCG effects on COVID-19 |
title_full_unstemmed | Two issues should be noted when designing a clinical trial to evaluate BCG effects on COVID-19 |
title_short | Two issues should be noted when designing a clinical trial to evaluate BCG effects on COVID-19 |
title_sort | two issues should be noted when designing a clinical trial to evaluate bcg effects on covid-19 |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242049/ https://www.ncbi.nlm.nih.gov/pubmed/37287961 http://dx.doi.org/10.3389/fimmu.2023.1207212 |
work_keys_str_mv | AT gongwenping twoissuesshouldbenotedwhendesigningaclinicaltrialtoevaluatebcgeffectsoncovid19 AT liuyinping twoissuesshouldbenotedwhendesigningaclinicaltrialtoevaluatebcgeffectsoncovid19 AT xueyong twoissuesshouldbenotedwhendesigningaclinicaltrialtoevaluatebcgeffectsoncovid19 AT zhuangli twoissuesshouldbenotedwhendesigningaclinicaltrialtoevaluatebcgeffectsoncovid19 |